Cardiology Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents
5 Questions

Mary Norine Walsh, MD, reflects on ACC presidency, changes in HF management

Cover Story

Cardiologists play key role in helping patients mitigate high genetic CVD risk

FDA News

FDA: OTC aspirin labels with CV imagery should prompt consumers to consult physician

FDA approves MR-conditional labeling for small pacemaker

Noninvasive 3D mapping system for arrhythmia location cleared by FDA

Next-generation troponin T test receives FDA clearance

Feature

Iron: An emerging target for HF

2 decades of MI

Cybersecurity concerns prompt discussion on remote monitoring

In the Journals

Mediterranean diet with virgin olive oil improves HDL function

Coronary plaque burden elevated in relatives of patients with CAD

Moderate chocolate intake confers lower risk for HF vs. heavy or no intake in men

Meal planning, timing may affect CHD risk, related risk factors

LV catheter ablation for certain arrhythmias may confer risk for brain lesions

LVADs improve quality of life, increase lifetime costs in patients with advanced HF

NSAIDs may increase myocardial infarction risk during acute respiratory infections

Proenkephalin A levels predictive of worsening renal status in patients with HF

Preterm delivery may increase CVD risk in women independent of other risk factors

Stroke risk higher with AF, insulin-requiring diabetes vs. without insulin

Regular exercise may reduce risk for hypertension in black adults

Novel BP loci may offer new therapeutic targets for hypertension

Worse outcomes related to elevated troponin levels in patients with decompensated HFpEF

Treatment to intensive systolic BP target could save 100,000 US lives annually

Women with lower socioeconomic status at higher risk for CHD, CVD than men

Dynamic resistance training may lower BP in patients with hypertension

AHA: Prevalence of HF projected to rise dramatically; CVD still No. 1 killer in US, world

Functional status improves in most children who survive 1 year after heart transplant

Depression confers risk for CVD in similar magnitude to obesity, high cholesterol in men

CAC in younger adults linked to substantially increased CHD risk

Consensus statement proposes standardized neurologic endpoints for CV trials

DAPT, aspirin monotherapy confer similar outcomes in patients with diabetes after CABG

Higher SYNTAX score may predict benefit from CABG vs. medical therapy

In patients undergoing noncardiac surgery, death and MI declining, but stroke increasing

Higher cardiac radiation exposure may increase HF risk in women with breast cancer

High TMAO level predicts CV events in patients with ACS

Genomic blood test predicts revascularization events in PROMISE cohort

Heart transplant listings increased in black patients with ACA Medicaid expansion

In the Journals Plus

Genetic predisposition to abdominal adiposity increases type 2 diabetes, CHD risks

Industry News

National Wear Red Day increases awareness of women’s heart health in its 14th year

Meeting News

Experts debate reimbursement, accreditation for carotid stenting

Therapeutic hypothermia fails to benefit children surviving in-hospital cardiac arrest

Vascular stent safe, effective in challenging long lesions

New balloon-expandable stent graft yields positive outcomes in iliac artery

Pharmacology Consult

The promise of a specific reversal agent for Factor Xa inhibitors

Laura Mentzer, PharmD, BCPS, BCCCP

Trial Scorecards

Trial Scorecard: ELSA – Brasil

Trial Scorecard: TWENTE

Trial Scorecard: CASABLANCA

Trial Scorecard: GLORIA-AF

Trial Scorecard: GARFIELD-AF

Trial Scorecard: SMART

Trial Scorecard: THAPCA-IH

Trial Scorecard: SORT OUT II

Advertisement
Advertisement